Braun Stacey Associates Inc Edwards Lifesciences Corp Transaction History

Braun Stacey Associates Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 28, 2019	SELL	$46.41 - $56.94 $2.37 Million - $2.9 Million	-50,974 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$45.7 - $58.03 $248,425 - $315,451	5,436 Added 11.94%	50,974 $8.87 Million
Q2 2018 Aug 01, 2018	BUY	$42.45 - $51.3 $1.93 Million - $2.34 Million	45,538 New	45,538 $6.63 Million
Q1 2018 May 01, 2018	SELL	$37.19 - $47.45 $1.6 Million - $2.04 Million	-43,096 Closed	0 $0
Q4 2017 Jan 30, 2018	SELL	$33.79 - $39.39 $125,496 - $146,294	-3,714 Reduced 7.93%	43,096 $4.86 Million
Q3 2017 Oct 25, 2017	BUY	$36.29 - $38.83 $1.7 Million - $1.82 Million	46,810	46,810 $5.12 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Braun Stacey Associates Inc, based on Form 13F filings with the SEC.

Stay updated on Braun Stacey Associates Inc with notifications on news.